Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2009-03-16

FDA Approved: HUMALOG MIX75/25 — Supplemental Application (Eli Lilly and Company)

View source ↗

Summary

FDA approves a supplemental application for HUMALOG MIX75/25 (insulin lispro premixed insulin) by Eli Lilly and Company.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Humalog Mix75/25 (Insulin lispro)

Snippet

SUPPL AP for HUMALOG MIX75/25 (INSULIN LISPRO)